Information about MAYAKU
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0755.350.975

VAT liability
Yes
Established
29-09-2020
Last balance sheet year
2024
Company size
Micro 1 FTE
Commercial name
Harpago
Full name
Mayaku Pharmaceutical Development
Principal activity
Manufacture of medicaments
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from MAYAKU

2024 2023 2022 2021
Profit/Loss 4,785 119 % -25,490 -73 % -14,743 -144 % 33,187
Equity -262 95 % -5,047 -125 % 20,443 -42 % 35,187
Gross margin 48,711 392 % -16,657 -40 % -11,868 -128 % 43,079
Employees 1

Publications from MAYAKU

Date Publication
28-04-2023 Registered Office (NL)
01-10-2020 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Mayaku Pharmaceutical Development?
The VAT number of Mayaku Pharmaceutical Development is BE 0755.350.975.
Wat is the PEPPOL ID of Mayaku Pharmaceutical Development?
The PEPPOL ID of Mayaku Pharmaceutical Development is 0208:0755350975. Log in or start a free trial to see the full overview.
When was Mayaku Pharmaceutical Development founded?
Mayaku Pharmaceutical Development was founded on 29-09-2020.
What is the address of Mayaku Pharmaceutical Development?
The current registered office of Mayaku Pharmaceutical Development is located at Technologiepark-Zwijnaarde 82, 9052 Gent.
When was the last time Mayaku Pharmaceutical Development filed their annual financial statements?
The most recent financial statements of Mayaku Pharmaceutical Development were filed on 02-07-2025.
How many employees does Mayaku Pharmaceutical Development have?
There are 1 FTEs working at Mayaku Pharmaceutical Development according to the staff figures in the most recent financial statements.
What is the annual turnover of Mayaku Pharmaceutical Development?
At the time of its most recent financial statements, Mayaku Pharmaceutical Development did not publish any turnover figures. Mayaku Pharmaceutical Development reported a gross margin of €48,711.32.